Company Overview
Snapshot
Founded in January 2016 by Gabriel Siegel and Dan Regelman, Augmentiqs operates with 1–10 employees. The company has secured funding across three rounds from the Israel Innovation Authority and Luminate NY Accelerator. In March 2020, Augmentiqs announced a new technical partnership and integration with Inspirata.
Business overview
Augmentiqs develops a digital pathology platform that transforms traditional microscopes into smart, connected devices. Its core technology integrates an embedded camera, augmented reality for the eyepiece, and real-time stage tracking directly within the microscope, enabling multi-directional communication with a PC. This platform allows pathologists to maintain optical quality while accessing pathology software from within the microscope. Augmentiqs serves the healthcare industry, including doctors, hospitals, and laboratories, by facilitating real-time telepathology, quantitative image analysis, AI training, LIS integration, and workflow tracking. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Decision Support.
Strategic signal
In March 2020, Augmentiqs announced a technical partnership and integration with Inspirata. This collaboration is significant as it validates Augmentiqs' technology within the digital pathology ecosystem and suggests a strategic move towards broader market adoption and enhanced functionality for pathologists. For investors, this signals potential for increased market penetration and a strengthened product offering through strategic alliances.
Log in to access full profile ›Company Intelligence Q&A
- What is Augmentiqs' primary focus?
- Augmentiqs focuses on transforming traditional microscopes into smart, connected digital pathology devices, integrating augmented reality and real-time tracking for enhanced diagnostic capabilities.
- When was Augmentiqs founded?
- Augmentiqs was founded in January 2016.
- Who are the founders of Augmentiqs?
- Augmentiqs was co-founded by Gabriel Siegel and Dan Regelman.
- What was a key strategic partnership for Augmentiqs?
- In March 2020, Augmentiqs announced a new technical partnership and integration with Inspirata, aiming to enhance digital pathology solutions.
- What type of funding has Augmentiqs received?
- Augmentiqs has received funding across three rounds, including a grant from the Israel Innovation Authority in March 2016 and support from the Luminate NY Accelerator in November 2018.